Abstract:The production of anti-tumor human monoclonal antibodies (MAbs) by human-human or human-mouse hybridoma technology was studied. UC729-6, a human lymphoblastoid cell line, or NS-1, a mouse myeloma cell line, were fused with lymphocytes isolated from regional lymph modes of 26 patients with breast or gastrointestinal cancer, resulting in 130 immunoglobulin-secreting human-human hybrids and 21 human-mouse hybrids. The supernatants of 88 hybrids were screened against a panel of cancer cells. The supernatants of 37 human-human hybrids and 2 human-mouse hybrids reacted with cancer cell lines. After three times subcloning, only one anti-breast cancer hybrid human MAb, IgG(lambda) human-human hybridoma (MUBL-6), and one anti-gastric cancer human MAb, IgM(lambda) human-mouse hybridoma (HMG-1), were obtained. The antibody-secreting level was 1-4 micrograms/ml/24 h. Production of anti-breast cancer human MAbs by Epstein-Barr virus (EBV) hybridoma was also studied. Human lymphocytes were derived from draining lymph nodes of a breast cancer patient, whose serum antibody strongly reacted with tumor associated antigen (TAA). The enriched B cells were transformed with EBV in vitro. Positive antibody-secreting B cells were selected, expanded, and fused with heteromyeloma SHMD-33. The fusion frequency was 28/10(7) lymphocytes. Among them were 16 hybridomas secreting human immunoglobulin. After subcloning, 60% of the cloned hybridomas kept their antibody-secreting ability. Six observed hybridomas remained stable for more than 1 year in tissue cultures. The antibody-secreting level was 2.9-30 micrograms/ml/24 h. Supernatants from these hybridomas all reacted with breast cancer cell lines but not with gastric cancer cell lines.(ABSTRACT TRUNCATED AT 250 WORDS)

ESTABLISHMENT OF HYBRIDOMA CELL LINES SECRETING ANTI-TERBUTALINE MONOCLONAL ANTIBODY AND PREPARATION, IDENTIFICATION OF ITS IMMUNOLOGICAL PROPERTIES

Preparation of a functional monoclonal antibody against human 4-1BBL molecule and analysis of its biological characteristics

Establishment of Hybridoma Cell Lines Secreting High-titred Monoclonal Antibodies to Oxytocin

Preparation of Tiamulin Artificial Complete Antigen and Development of Its Monoclonal Antibody

ESTABLISHMENT OF HYBRIDOMA CELL LINES SECRETING ANTI-CIMATEROL MONOCLONAL ANTIBODY AND PREPARATION,IDENTIFICATION OF THEIR IMMUNOLOGICAL PROPERTIES

Preparation and Immunological Characterization of Monoclonal Antibody Against Ochratoxin A

Production of Monoclonal Antibodies Against Thiabendazole and Development of Heterologous IC-ELISA

Preparation and Characterization of a Monoclonal Antibody Against Human B Lymphocyte Stimulator

Preparation of Anti-Human 4-1BB Monoclonal Antibody and Analysis of Its Biological Functions

Establishment of Hybridoma Cell Strain Secreting McAbs Against IBDV

Production of Anti-Tumor Human Monoclonal Antibodies Using Different Approaches.

Preparation and Biological Identification of a Functional Monoclonal Antibody,mouse Anti-Human B and T Lymphocyte Attenuator

Production and preliminary application of anti-staphylococcal enterotoxinB monoclonal antibodies

Preparation of Hybridoma Cell Strains Secreting Monoclonal Antibodies Against Domic Acid

Preparation, Immunological Characterization and Polyclonal Antibody Development for Recombinant Epitope Tandem Derived from Bovineβ-Lactoglobulin

ESTABLISHMENT OF FOUR HYBRIDOMA CELL LINES SECRETING ANTI-HUMAN IGA MCABS

The Perparation of Monoclonal Antibody Against MBzP

Preparation and Characterization of a Functional Monoclonal Antibody Against Human Tumor Necrosis Factor and B Lymphocyte Stimulator

ESTABLISHMENT OF THE HYBRIDOMA SECRETING McAb SPECIFIC FOR HUMAN ERYTHROCYTE MEMBRANE

Synthesis and Identification of Ochratoxin A Artificial Immunogen

The Establishment of Hybridoma Cell Lines Producing McAbs against Antibacterial Peptide from Bombyx Mori